OCTIMET Oncology
Beerse
About OCTIMET Oncology
OCTIMET oncology’s overall strategy is to advance the development of discovery stage molecules by employing innovative patient selection and pharmacodynamic biomarker-based strategies, as well as an innovative clinical development strategy.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $13.3M
- Funding stage: Early Stage Venture
- Last round: Grant (Aug 2018)
- Website: octimet.com
- Phone: +32473558353
Industries & Categories
Biotechnology, Medical
Social Profiles
Canonical: https://fsome.com/organization/octimet-oncology-66073 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.